Dieser SARS-CoV-2 NSP9 Antikörper ist unkonjugiert
Applikation
ELISA, Western Blotting (WB)
Aufreinigung
SARS-CoV-2 (COVID-19) NSP9 Antibody is affinity chromatography purified via peptide column.
Immunogen
Anti-SARS-CoV-2 (COVID-19) NSP9 antibody was raised against a peptide corresponding to 14 amino acids near the carboxyl terminus of SARS-CoV-2 (COVID-19) NSP9 protein. The immunogen is located within the last 50 amino acids of the SARS-CoV-2 (COVID-19) NSP9 protein
Antibody validated: SARS-CoV-2 (COVID-19) NSP9 antibody can detect 2 ng of free peptide at 1 μ,g/mL in ELISA.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
1 mg/mL
Buffer
SARS-CoV-2 (COVID-19) NSP9 Antibody is supplied in PBS containing 0.02 % sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
-20 °C,4 °C
Informationen zur Lagerung
SARS-CoV-2 (COVID-19) NSP9 antibody can be stored at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Target
SARS-CoV-2 NSP9 (NSP9)
(SARS-CoV-2 Non-Structural Protein 9 (NSP9))
Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019-20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP9 may participate in viral replication by acting as a ssRNA-binding protein (3).